Cargando…

Metabolomics studies on cachexia in patients with cancer: a scoping review protocol

INTRODUCTION: Cancer seriously threatens human health worldwide. Cancer cachexia is one of the life-threatening consequences that occurs commonly in patients with cancer, and severely worsens patient survival, prognosis and quality of life. Previous studies have demonstrated that cancer cachexia is...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Liang, Chen, Lin, Li, Rufang, Xu, Wenxia, Fu, Jianfei, Ye, Xianghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006824/
https://www.ncbi.nlm.nih.gov/pubmed/35414542
http://dx.doi.org/10.1136/bmjopen-2021-052125
_version_ 1784686742027108352
author Fu, Liang
Chen, Lin
Li, Rufang
Xu, Wenxia
Fu, Jianfei
Ye, Xianghong
author_facet Fu, Liang
Chen, Lin
Li, Rufang
Xu, Wenxia
Fu, Jianfei
Ye, Xianghong
author_sort Fu, Liang
collection PubMed
description INTRODUCTION: Cancer seriously threatens human health worldwide. Cancer cachexia is one of the life-threatening consequences that occurs commonly in patients with cancer, and severely worsens patient survival, prognosis and quality of life. Previous studies have demonstrated that cancer cachexia is closely related to differential metabolites and metabolic pathways based on metabolomics analysis. This scoping review protocol, therefore, aims to provide the strategy for a formal scoping review that will summarise the differential metabolites and related metabolic pathways of cachexia in patients with cancer. METHODS AND ANALYSIS: The proposed scoping review will follow the Arksey and O’Malley’s methodological framework, Levac et al’s recommendations for applying this framework, and Peters’ enhancements of the framework. The key information from the selected studies will be extracted, including author, year of publication, cachexia definition, country/origin, study design, setting, population and sample size, biological specimens, independent variables, independent variables’ measure and statistical analysis. A summary of metabolites will be divided into several sections depending on the biological specimen. Differential metabolites will be compared between paired groups, and the number and names of related metabolic pathways will be counted and described. The reporting of this scoping review will be in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. This is a scoping review protocol and describes the planned review process and provides data examples extracted from a pilot study to confirm the feasibility of further investigation of the subject. ETHICS AND DISSEMINATION: An ethical approval is not required for this scoping review protocol, nor for the scoping review. The results of this scoping review will be disseminated through publication in a peer-reviewed journal, or presentation at a national or international conference.
format Online
Article
Text
id pubmed-9006824
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90068242022-05-02 Metabolomics studies on cachexia in patients with cancer: a scoping review protocol Fu, Liang Chen, Lin Li, Rufang Xu, Wenxia Fu, Jianfei Ye, Xianghong BMJ Open Oncology INTRODUCTION: Cancer seriously threatens human health worldwide. Cancer cachexia is one of the life-threatening consequences that occurs commonly in patients with cancer, and severely worsens patient survival, prognosis and quality of life. Previous studies have demonstrated that cancer cachexia is closely related to differential metabolites and metabolic pathways based on metabolomics analysis. This scoping review protocol, therefore, aims to provide the strategy for a formal scoping review that will summarise the differential metabolites and related metabolic pathways of cachexia in patients with cancer. METHODS AND ANALYSIS: The proposed scoping review will follow the Arksey and O’Malley’s methodological framework, Levac et al’s recommendations for applying this framework, and Peters’ enhancements of the framework. The key information from the selected studies will be extracted, including author, year of publication, cachexia definition, country/origin, study design, setting, population and sample size, biological specimens, independent variables, independent variables’ measure and statistical analysis. A summary of metabolites will be divided into several sections depending on the biological specimen. Differential metabolites will be compared between paired groups, and the number and names of related metabolic pathways will be counted and described. The reporting of this scoping review will be in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist. This is a scoping review protocol and describes the planned review process and provides data examples extracted from a pilot study to confirm the feasibility of further investigation of the subject. ETHICS AND DISSEMINATION: An ethical approval is not required for this scoping review protocol, nor for the scoping review. The results of this scoping review will be disseminated through publication in a peer-reviewed journal, or presentation at a national or international conference. BMJ Publishing Group 2022-04-11 /pmc/articles/PMC9006824/ /pubmed/35414542 http://dx.doi.org/10.1136/bmjopen-2021-052125 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Fu, Liang
Chen, Lin
Li, Rufang
Xu, Wenxia
Fu, Jianfei
Ye, Xianghong
Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
title Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
title_full Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
title_fullStr Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
title_full_unstemmed Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
title_short Metabolomics studies on cachexia in patients with cancer: a scoping review protocol
title_sort metabolomics studies on cachexia in patients with cancer: a scoping review protocol
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006824/
https://www.ncbi.nlm.nih.gov/pubmed/35414542
http://dx.doi.org/10.1136/bmjopen-2021-052125
work_keys_str_mv AT fuliang metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol
AT chenlin metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol
AT lirufang metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol
AT xuwenxia metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol
AT fujianfei metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol
AT yexianghong metabolomicsstudiesoncachexiainpatientswithcancerascopingreviewprotocol